SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 199 filers reported holding SEATTLE GENETICS INC in Q2 2013. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $2,038,000 | +7.4% | 53,263 | +27.8% | 0.06% | -6.5% |
| Q1 2014 | $1,898,000 | +14.4% | 41,663 | +0.2% | 0.06% | +19.2% |
| Q4 2013 | $1,659,000 | -44.8% | 41,600 | -39.4% | 0.05% | -47.5% |
| Q3 2013 | $3,006,000 | +129.6% | 68,600 | +64.9% | 0.10% | -71.9% |
| Q2 2013 | $1,309,000 | – | 41,600 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |